[go: up one dir, main page]

IT1319275B1 - Uso del baclofen nel trattamento dell'astinenza da etanolo. - Google Patents

Uso del baclofen nel trattamento dell'astinenza da etanolo.

Info

Publication number
IT1319275B1
IT1319275B1 IT1999MI002107A ITMI992107A IT1319275B1 IT 1319275 B1 IT1319275 B1 IT 1319275B1 IT 1999MI002107 A IT1999MI002107 A IT 1999MI002107A IT MI992107 A ITMI992107 A IT MI992107A IT 1319275 B1 IT1319275 B1 IT 1319275B1
Authority
IT
Italy
Prior art keywords
baclofen
treatment
abstinence
ethanol
ethanol abstinence
Prior art date
Application number
IT1999MI002107A
Other languages
English (en)
Inventor
Gian Luigi Gessa
Giancarlo Colombo
Giovanni Addolorato
Original Assignee
Neuroscienze S C A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuroscienze S C A R L filed Critical Neuroscienze S C A R L
Publication of ITMI992107A0 publication Critical patent/ITMI992107A0/it
Priority to IT1999MI002107A priority Critical patent/IT1319275B1/it
Priority to DK00969423T priority patent/DK1217999T3/da
Priority to DE60021590T priority patent/DE60021590T2/de
Priority to HK02109321.9A priority patent/HK1048062A1/zh
Priority to ES00969423T priority patent/ES2246900T3/es
Priority to EP00969423A priority patent/EP1217999B1/en
Priority to CA002386817A priority patent/CA2386817C/en
Priority to PL354083A priority patent/PL200525B1/pl
Priority to AT00969423T priority patent/ATE300295T1/de
Priority to AU79146/00A priority patent/AU7914600A/en
Priority to PCT/EP2000/009750 priority patent/WO2001026638A2/en
Publication of ITMI992107A1 publication Critical patent/ITMI992107A1/it
Application granted granted Critical
Publication of IT1319275B1 publication Critical patent/IT1319275B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT1999MI002107A 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo. IT1319275B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT1999MI002107A IT1319275B1 (it) 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo.
CA002386817A CA2386817C (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcoholism
DE60021590T DE60021590T2 (de) 1999-10-08 2000-10-05 Verwendung von baclofen zur behandlung von alkoholismus
HK02109321.9A HK1048062A1 (zh) 1999-10-08 2000-10-05 巴氯酚(baclofen)在酒精中毒治療中的應用
ES00969423T ES2246900T3 (es) 1999-10-08 2000-10-05 Uso de baclofeno en el tratamiento del alcoholismo.
EP00969423A EP1217999B1 (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcoholism
DK00969423T DK1217999T3 (da) 1999-10-08 2000-10-05 Anvendelse af baclofen til behandling af alkoholisme
PL354083A PL200525B1 (pl) 1999-10-08 2000-10-05 Zastosowanie baklofenu do wytwarzania leku
AT00969423T ATE300295T1 (de) 1999-10-08 2000-10-05 Verwendung von baclofen zur behandlung von alkoholismus
AU79146/00A AU7914600A (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcohol withdrawal syndrome and to promote alcohol abstinence in alcoholics
PCT/EP2000/009750 WO2001026638A2 (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcoholism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI002107A IT1319275B1 (it) 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo.

Publications (3)

Publication Number Publication Date
ITMI992107A0 ITMI992107A0 (it) 1999-10-08
ITMI992107A1 ITMI992107A1 (it) 2001-04-08
IT1319275B1 true IT1319275B1 (it) 2003-09-26

Family

ID=11383744

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI002107A IT1319275B1 (it) 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo.

Country Status (11)

Country Link
EP (1) EP1217999B1 (it)
AT (1) ATE300295T1 (it)
AU (1) AU7914600A (it)
CA (1) CA2386817C (it)
DE (1) DE60021590T2 (it)
DK (1) DK1217999T3 (it)
ES (1) ES2246900T3 (it)
HK (1) HK1048062A1 (it)
IT (1) IT1319275B1 (it)
PL (1) PL200525B1 (it)
WO (1) WO2001026638A2 (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
AU2004267100B2 (en) 2003-08-20 2010-10-07 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
EP2354120A1 (en) 2003-08-20 2011-08-10 XenoPort, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
US7494985B2 (en) 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
US7566738B2 (en) 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
WO2008033572A1 (en) 2006-09-15 2008-03-20 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
US8062870B2 (en) 2008-01-25 2011-11-22 Xenoport, Inc. Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
EP2250148B1 (en) 2008-01-25 2016-08-17 XenoPort, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use
US8299291B2 (en) 2008-08-07 2012-10-30 Xenoport, Inc. Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs
WO2010017498A1 (en) 2008-08-07 2010-02-11 Xenoport, Inc. Methods of synthesizing n-hydroxysuccinimidyl carbonates
US10071068B2 (en) 2009-03-03 2018-09-11 Xenoport, Inc. Sustained release oral dosage forms of an R-baclofen prodrug
WO2010120370A2 (en) 2009-04-17 2010-10-21 Xenoport, Inc. Gamma-amino-butyric acid derivatives as gabab receptor ligands
DE102010011069A1 (de) 2010-03-11 2011-09-15 Susanne Haamann Verfahren zur gezielten pharmakologischen und co-psychotherapeutischen Behandlung der Alkoholabhängigkeit mit Baclofen und Nalmefen
US8580850B2 (en) 2011-08-11 2013-11-12 Xenoport, Inc. Anhydrous and hemihydrate crystalline forms of an (R)-baclofen prodrug, methods of synthesis and methods of use
WO2016115504A1 (en) * 2015-01-15 2016-07-21 Allaysis, Llc Intravenous baclofen formulations and treatment methods

Also Published As

Publication number Publication date
ATE300295T1 (de) 2005-08-15
CA2386817A1 (en) 2001-04-19
ITMI992107A1 (it) 2001-04-08
CA2386817C (en) 2009-05-12
ES2246900T3 (es) 2006-03-01
HK1048062A1 (zh) 2003-03-21
WO2001026638A3 (en) 2002-02-28
DE60021590D1 (de) 2005-09-01
EP1217999B1 (en) 2005-07-27
ITMI992107A0 (it) 1999-10-08
WO2001026638A2 (en) 2001-04-19
PL200525B1 (pl) 2009-01-30
AU7914600A (en) 2001-04-23
PL354083A1 (en) 2003-12-29
EP1217999A2 (en) 2002-07-03
DE60021590T2 (de) 2006-05-24
DK1217999T3 (da) 2005-11-28

Similar Documents

Publication Publication Date Title
IT1319275B1 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo.
MX9700534A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para tratar las enfermedades de prostata, endometriosis y obesidad.
NO20024309D0 (no) Intradermal penetreringsmidler for topikal lokal anestetisk administrering
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
AR006484A1 (es) Composición farmacéutica con efecto anestésico, uso de esta composición para la fabricación de medicamentos, y proceso para la fabricación de esta composición .
NO971568D0 (no) Analoger av keratinocyttvekstfaktor
ATE333896T1 (de) Vaskularisierungsinhibitoren
ES2167401T3 (es) Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
CY1104971T1 (el) Παρασκευασμα αποϊνιδοτιδιου και g-csf και η χρηση του για να κινητοποιει αιμοποιητικους προγονους
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
AR031601A1 (es) Derivados de 4-pirimidinamina, composiciones farmaceuticas y metodos relacionados
DK0391185T3 (da) 1,8-Naphthyridiner
NO974708D0 (no) Levobupivacain og dets anvendelse som anestetikum i gravide kvinner
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
ES2183890T3 (es) Uso del factor de crecimiento de hepatocitos para in estimular la proliferacion y diferenciacion de celulas hematopoyeticas.
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
ES2173180T3 (es) Derivados del mercaptoacetilamida hipocolesterolemicos, antiateroescleroticos e hipotrigliceridemicos.
AU9028098A (en) Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
TR200001075T2 (tr) Tiamfenikol ve diklofenak içeren bileşimler.
MD916G2 (ro) Unguent pentru tratamentul afecţiunilor dentare
IT1276040B1 (it) Uso della benzidamina nel trattamento di stati patologici causati dal tnf
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.
RO99683B1 (ro) Solutie medicamentoasa de uz topic cu efect antiinflamator si antireumatic